Expression of NKG2D ligands on tumor cells render them more sensitive to immunological destruction by engaging NKG2D receptor to trigger NK cells, γδ T cells and provide costimulatory signal for CD8 T cells [16,17]. Here, KLRK1 is linked to neoplasm.